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Although cardiac myxoma is rare, it is the most common
primary cardiac tumor. Seventy-four cases of cardiac myxoma
that were surgically treated in our center between August 1980
and February 2005 were retrospectively reviewed. The mean
patient age was 50.4 ± 15.0 (range 7-80) years, and 53
patients (71.6%) were female. The most common preoperative
symptom, occurring in 44 patients, was dyspnea. The interval
from onset of symptoms to surgery was 9 months. Seventy
cases were located in the left atrium, 3 in the right atrium and
1 in the right ventricle. The myxoma in the right ventricle
could not be resected completely, due to severe infiltration.
Cardiopulmonary bypass and aortic cross clamp times were
100.4 ± 37.1 and 64.8 ± 29.8 minutes, respectively. There
were no hospital deaths, and 7 patients suffered from post-
operative complications including atrial fibrillation in 2 cases.
During the follow up period (mean 105.7 ± 73.6 months),
there was no tumor recurrence and 6 late deaths that were not
related to the underlying tumor. There was no evidence of
tumor growth in the cases with incomplete resection during the
14-month follow-up. In conclusion, in this study there was no
recurrence of tumors after complete resection and surgical
resection is considered to be the curative method of treatment
for cardiac myxoma.
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INTRODUCTION
Cardiac myxoma is a rare disease with an
overall incidence of about 0.5/million/year1 and
accounts for approximately 70 percent of all pri-
mary cardiac tumors.5 Several studies of cardiac
myxoma involving large sample sizes have been
reported in the past decade.2-4 Recently, well
developed preoperative diagnostic techniques,
especially echocardiography, have enabled earlier
detection than was previously possible. Therefore,
the number of patients who undergo surgery has
increased, and long-term results have improved.
This report reviews patients who underwent
surgery for cardiac myxoma in our center and the
long-term results of treatment.
MATERIALS AND METHODS
Seventy-four patients underwent surgery for
cardiac myxoma in the Yonsei Cardiovascular
Center between August 1980 and February 2005.
The medical records were retrospectively re-
viewed and some patients were contacted by tele-
phone for follow-up. During this period, cardiac
myxoma was the most common primary cardiac
tumor in our center, comprising 81.4% of all pri-
mary cardiac tumors. Twenty-one patients (28.4
%) were male and 53 (71.6%) were female (Table
1), and the mean age was 50.4 ± 15.0 years (range,
7 to 80 years). The locations of tumors were: left
atrium in 70 patients, right atrium in three
patients, and right ventricular septum in one
patient. Preoperative symptoms were dyspnea,
which occurred in 44 patients (59.5%), an embolic
event in 8 (10.8%), palpitations in 9 (12.2%), chest
pain in 8 (10.8%), and neurologic symptoms such
as dizziness or syncope in 5 (7.1%). One patient,
who underwent an emergency Fogarty embolec-
tomy of both iliac arteries due to acute embolism,
was found to have myxoma of the heart and un-
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derwent surgery for cardiac myxoma. In another
patient, cardiac myxoma was found incidentally
during a procedure for a ventricular septal defect
and aortic regurgitation. Twenty patients (27.0%)
were greater than functional class III of the New
York Heart Association. Forty- two patients were
diagnosed by transthoracic echocardiography
only, while thirty-two patients required both
transthoracic and transesophageal echocardio-
grams for more accurate anatomic descriptions.
All patients over 40 years of age underwent a
coronary angiogram to rule out coronary disease.
Only one patient who showed shortness of breath
was diagnosed as having coronary artery ob-
structive disease. The mean duration from onset
of symptoms to diagnosis was about nine months
(range, 1 week to 180 months). Chest X-rays
showed abnormalities in 21 patients (28.4%), in-
cluding cardiomegaly, pulmonary edema, and
pleural effusion. Electrocardiography showed
abnormalities in 36 patients (48.6%), including
atrial fibrillation, left atrial enlargement, and right
axis deviation. These abnormalities are frequently
seen in mitral valve stenosis. Median sternotomy
was performed in all patients, and the operative
procedure was performed under moderate hypo-
thermia and an arrested heart with cardiopul-
moary bypass (Table 2). The mean cardiopul-
monary bypass time and aortic cross clamp time
were 100.4 ± 37.1 and 64.8 ± 29.8 minutes, re-
spectively. The size variation of tumors was from
1 × 1 × 1 cm to 12 × 5 × 3 cm. In 70 cases, the
tumor was located in the left atrium, of which 60
cases (81.1%) were derived from the septum, five
cases (6.8%) from the free wall, three cases (4.1%)
from both the left atrial septum and the free wall,
and one each from the orifice of the left pul-
monary vein and the anterior leaflet of the mitral
valve. If the tumor was located in the left atrial
side, the vent sucker was inserted after opening
of the left atrium and aortic cross clamping. In
three cases, the tumor was in the right atrium,
with two of those involving the right atrial sep-
tum and one involving the free wall. The re-
maining case involved a tumor on the septal wall
of the right ventricle. One patient had two
Table 1. Clinical Features
Features No. Percent (%)
Sex
Female 49 70
Male 21 30
Location of tumor
LA septum 57 81.4
LA wall 4 5.7
LA wall & septum 3 4.3
LIPV orifice 1 1.4
Anterior leaflet of mitral valve 1 1.4
RA septum 2 2.9
RA wall 1 1.4
RV septum 1 1.4
Symptoms
Dyspnea 44 62.9
Embolism 7 10
Palpitation 8 11.4
Chest pain 7 10
Neurologic 5 7.1
LA, left atrial; RA, right atrial; RV, right ventricular; LIPV, left inferior pulmonary vein; MV, mitral valve.
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separate tumors in the left atrium, with sizes of
8 × 4 × 3 cm and 6 × 4 × 3 cm. Another patient,
whose sister had also undergone surgery for
cardiac myxoma at another hospital, had three
separate tumors in the left atrium, with sizes of
approximately 2 × 1.5 × 1 cm. For resection of the
tumors, 38 patients (54.3%) required a biatrial
approach, 26 patients (37.1%) required a right
atrial approach, and 10 patients (14.3%) required
a left atrial approach. Where possible, tumors
were resected with the en bloc method for
complete resection and visual examination was
then performed to prevent postoperative embolic
events. For repair of a defective area, autologous
pericardium or an artificial patch was used in 52
patients (70.3%), and direct closures were possible
in 20 patients (27.0%). The myxoma located in the
septum of the right ventricle was resected
incompletely due to severe attachment with the
septal wall. The following associated procedures
were performed: mitral annuloplasty in three
cases, tricuspid annuloplasty in three cases, coro-
nary artery bypass graft with mitral annuloplasty
in one, aortic valve replacement with patch repair
of a ventricular septal defect in one, and mitral
valve replacement in one.
RESULTS
The mean durations of stay in the intensive care
unit and hospital were 2.3 ± 1.3 days and 11.9 ±7.6
days, respectively. There were no operative
mortalities but seven cases (9.5%) of postoperative
complications: two cases of atrial fibrillation and
one case each of mitral regurgitation, periopera-
tive myocardial infarction, pneumonia, sepsis, and
wound complication (Table 3). All patients re-
covered from their postoperative conditions ex-
cept for the 59 year-old patient with mitral regur-
Table 3. Surgical Results
Results No. Percent (%)
Early mortality 0 0
Early morbidity 7 10.0
Atrial fibrillation 2 2.9
Mitral regurgitation 1 1.4
Perioperative myocardial infarction 1 1.4
Late mortality 6 8.6
Table 2. Operation Methods
Methods No. Percent (%)
Left atriotomy 8 11.4
Right atriotomy 25 35.7
Biatrial approach 37 52.9
Patch repair of defect 48 68.6
Direct closure of defect 20 28.6
MV annuloplasty 3 4.3
CABG & MV annuloplasty 1 1.4
AVR & patch repair of VSD 1 1.4
Mitral valve replacement 1 1.4
TV annuloplasty 1 1.4
MV, mitral valve; CABG, coronary artery bypass graft; AVR, aortic valve replacement; VSD, ventricular septal defect; TV,
tricuspid valve.
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gitation. The cause of this regurgitation was
thought to be incidental injury to the mitral valve
leaflet; this patient underwent mitral valve re-
placement with a tissue valve on the first post-
operative day. All patients underwent an echo-
cardiogram before discharge to evaluate the
possibility of residual tumor. During follow up
echocardiography was performed as required by
the physician according to patients’ symptoms.
All patients received follow-up for a mean dura-
tion of 105.7 ± 73.6 months. There were six (8.6%)
late deaths; however, there was no evidence that
these deaths were directly related to cardiac
myxoma. In 13 patients electrocardiographic ab-
normalities that were present before surgery had
disappeared. The patient who underwent mitral
valve replacement on the first postoperative day
needed a second mitral valve replacement 12
years later due to severe mitral regurgitation of
the tissue valve. There was no increase in tumor
size during the 14 month follow-up period in the
patient whose tumor was incompletely resected
due to severe attachment with the right ventricu-
lar septum. The remaining 73 patients, including
the late deaths, showed no evidence of tumor
recurrence clinically or on echocardiograms
(between 7 days to 282 months postoperatively)
during the follow-up period.
DISCUSSION
About 90 percent of primary cardiac tumors are
known to be benign tumors.6 Cardiac myxoma
comprises about 70 to 80 percent of primary
cardiac tumors and are the most commonly
operated on. Since cardiac myxoma exhibits rapid
growth most patients show advanced symptoms
at the time of surgery.
2
However, if the tumor is
resected completely, the recurrence rate is very
low.2,4 Possible risk factors for recurrence of car-
diac myxoma include incomplete resection, intra-
cardiac implantation, embolization, and a reserve
of tumor precursor cells in the subendocardium.3
It has been reported that preoperative symptoms
are most commonly embolism or heart failure due
to obstructive lesions, and emergency surgery is
required in cases showing embolic symptoms.3
The risk of embolism is higher for polypoid or
multilobular shaped tumors than round ones.7,8
Therefore, if a polypoid or multilobular shaped
myxoma is suspected on preoperative echocardio-
graphy, urgent surgical intervention is necessary
to prevent an embolism. Recent studies on the
resection of cardiac myxoma with normal cardiac
tissues indicated that there was no difference in
recurrence rates between patients who underwent
an en bloc resection and resection with only endo-
cardial tissue attached with the tumor.9 However,
the type of resection depends largely on factors
such as the location of the tumor and the shape
of tumor stalks. In the present study, repair of a
large defective area with autologous or artificial
patches after tumor resection was necessary in 48
cases, and one case required re-operation due to
excessive resection of the mitral valve tissues.
Incomplete resection may result in cases where
the tumor is attached to the mitral valve or
conduction tissue, or occurs in the ventricular
septum. Endocardial resection of the tumor is
considered acceptable if postoperative complica-
tions are expected due to excessive resection of
tissue, or if the tumor has a narrow based stalk
attached to the endocardium.
Centofanti and associates reported that four-
chamber examination after tumor resection for the
removal of remaining tumor tissues or debris is
not warranted due to the recent development of
perioperative transesophageal echocardiography.9
However we feel that, whenever possible, a
thorough visual examination is beneficial for the
prevention of postoperative embolism. In the
majority of our cases the biatrial approach was
used, allowing more thorough examinations. As
reported by Jones and associates,
10
the advan-
tages of the biatrial approach are: direct visuali-
zation allowing a more clearly defined tumor
pedicle, minimal manipulation of the tumor,
adequate margins of excision, inspection of all
heart chambers, and secure closure of the atrial
septal defect. Familial myxoma accounts for 5% of
cases, and it is known to recur even after several
decades.
2,11
Although one of our cases was sus-
pected to be familial myxoma, there was no evi-
dence of recurrence during the follow-up period.
Thorough examination of the patient’s past
history and family history was needed in this
case, and regular follow-up was essential. In our
Cardiac Myxoma
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study there was one case of incomplete resection
due to severe infiltration to the right ventricular
septum. Gawdzinski and associates reported a
similar case of right ventricular myxoma, and
performed endocardial decortication of the right
ventriclular septum and a tricuspid valve re-
placement due to tricuspid valve involvement.12
However, the patient underwent re-operation
after three months due to severe thrombotic tri-
cuspid valve obstruction and recurrence of the
tumor. In the present case, there was no increase
in tumor size and no thrombotic evidence in the
final follow up echocardiogram performed 10
months after the operation. However, thorough
follow-up is important for this young patient.
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